Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial

Journal of the American Heart Association

Volumn 4, Issue 5, 2015, Pages

  Wu, Jason H Y ^a   Marchioli, Roberto ^b   Silletta, Maria G ^c   Masson, Serge ^c   Sellke, Frank W ^d   Libby, Peter ^e   Milne, Ginger L ^f   Brown, Nancy J ^g   Lombardi, Federico ^h   Damiano, Ralph J ⁱ   Marsala, Joann ⁱ   Rinaldi, Mauro ^j   Domenech, Alberto ^k   Simon, Caterina ^l   Tavazzi, Luigi ^m   Mozaffarian, Dariush ⁿ  

^a UNIVERSITY OF SYDNEY   (Australia)

^b IQVIA   (United States)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d BROWN UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF TURIN   (Italy)

^k HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^l OSPEDALI RIUNITI   (Italy)

^m MARIA CECILIA HOSPITAL   (Italy)

ⁿ TUFTS UNIVERSITY   (United States)

more..

Author keywords

atrial fibrillation; cardiac surgery; isofurans; isoprostanes; oxidative stress

Indexed keywords

BIOLOGICAL MARKER; EDIBLE OIL; ISOPROSTANE DERIVATIVE; OMEGA 3 FATTY ACID;

ATRIAL FIBRILLATION; BLOOD; CLINICAL TRIAL; DIET THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; BIOMARKERS; DIETARY FATS, UNSATURATED; ELECTROCARDIOGRAPHY; F2-ISOPROSTANES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INCIDENCE; ISOPROSTANES; MALE; MIDDLE AGED; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; TREATMENT OUTCOME;

EID: 84995771666     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.001886     Document Type: Article

References (36)

1. Mitchell LB. Canadian cardiovascular society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery. Can J Cardiol. 2011;27:91–97.
2. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U. Post-operative atrial fibrillation: a maze of mechanisms. Europace. 2012;14:159–174.
3. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res. 2001;89:E32–E38.
4. Nishijima Y, Sridhar A, Bonilla I, Velayutham M, Khan M, Terentyeva R, Li C, Kuppusamy P, Elton TS, Terentyev D, Gyorke S, Zweier JL, Cardounel AJ, Carnes CA. Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res. 2011;91:71–79.
5. Lenaerts I, Driesen RB, Hermida N, Holemans P, Heidbuchel H, Janssens S, Balligand JL, Sipido KR, Willems R. Role of nitric oxide and oxidative stress in a sheep model of persistent atrial fibrillation. Europace. 2013;15:754–760.
6. Pinho-Gomes AC, Reilly S, Brandes RP, Casadei B. Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. Antioxid Redox Signal. 2014;20:1268–1285.
7. Granger DN, Vowinkel T, Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension. 2004;43:924–931.
8. Antoniades C, Demosthenous M, Reilly S, Margaritis M, Zhang MH, Antonopoulos A, Marinou K, Nahar K, Jayaram R, Tousoulis D, Bakogiannis C, Sayeed R, Triantafyllou C, Koumallos N, Psarros C, Miliou A, Stefanadis C, Channon KM, Casadei B. Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. J Am Coll Cardiol. 2012;59:60–70.
9. Kim YM, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51:68–74.
10. Girerd N, Pibarot P, Fournier D, Daleau P, Voisine P, O'Hara G, Despres JP, Mathieu P. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J. 2009;30:1270–1278.
11. Ramlawi B, Otu H, Mieno S, Boodhwani M, Sodha NR, Clements RT, Bianchi C, Sellke FW. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg. 2007;84:1166–1172; discussion 1172-1163.
12. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ II, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCL4 poisoning? Free Radic Biol Med. 2005;38:698–710.
13. Ulus AT, Aksoyek A, Ozkan M, Katircioglu SF, Basu S. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic Biol Med. 2003;34:911–917.
14. Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ, Latini R, Libby P, Lombardi F, O'Gara PT, Page RL, Tavazzi L, Tognoni G. Fish oil and postoperative atrial fibrillation: the omega-3 fatty acids for prevention of post-operative atrial fibrillation (OPERA) randomized trial. JAMA. 2012;308:2001–2011.
15. Roberts LJ II, Milne GL. Isoprostanes. J Lipid Res. 2009;50(suppl):S219–S223.
16. Fessel JP, Jackson Roberts L. Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension. Antioxid Redox Signal. 2005;7:202–209.
17. Mozaffarian D, Marchioli R, Gardner T, Ferrazzi P, O'Gara P, Latini R, Libby P, Lombardi F, Macchia A, Page R, Santini M, Tavazzi L, Tognoni G. The omega-3 fatty acids for prevention of post-operative atrial fibrillation trial—rationale and design. Am Heart J. 2011;162:56–63.e53.
18. Wu JH, Marchioli R, Silletta MG, Macchia A, Song X, Siscovick DS, Harris WS, Masson S, Latini R, Albert C, Brown NJ, Lamarra M, Favaloro RR, Mozaffarian D. Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial. J Am Heart Assoc. 2013;2:e000397 doi: 10.1161/JAHA.113.000397.
19. Milne GL, Gao B, Terry ES, Zackert WE, Sanchez SC. Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry. Free Radic Biol Med. 2013;59:36–44.
20. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J. 2003;24:881–882.
21. Sovari AA, Dudley SC. Antioxidant therapy for atrial fibrillation: lost in translation? Heart. 2012;98:1615–1616.
22. Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep. 2010;12:135–142.
23. Grieve DJ, Shah AM. Oxidative stress in heart failure. More than just damage. Eur Heart J. 2003;24:2161–2163.
24. Li Y, Sheng L, Li W, Liu W, Gong Y, Xue H, Shan H. Probucol attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in dogs. Biochem Biophys Res Commun. 2009;381:198–203.
25. Fukunaga N, Takahashi N, Hagiwara S, Kume O, Fukui A, Teshima Y, Shinohara T, Nawata T, Hara M, Noguchi T, Saikawa T. Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress. Heart Rhythm. 2012;9:2023–2031.
26. Youn JY, Zhang J, Zhang Y, Chen H, Liu D, Ping P, Weiss JN, Cai H. Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol. 2013;62:72–79.
27. Wu JH, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, Heckbert SR, Siscovick DS, Mozaffarian D. Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the Cardiovascular Health Study. Circulation. 2012;125:1084–1093.
28. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047–2067.
29. Leitinger N, Huber J, Rizza C, Mechtcheriakova D, Bochkov V, Koshelnick Y, Berliner JA, Binder BR. The isoprostane 8-iso-PGF(2alpha) stimulates endothelial cells to bind monocytes: differences from thromboxane-mediated endothelial activation. FASEB J. 2001;15:1254–1256.
30. Huber J, Bochkov VN, Binder BR, Leitinger N. The isoprostane 8-iso-PGE2 stimulates endothelial cells to bind monocytes via cyclic AMP- and p38 MAP kinase-dependent signaling pathways. Antioxid Redox Signal. 2003;5:163–169.
31. Chambers DJ. Oxidative stress injury during cardiac surgery: how important is it? Cardiovasc Res. 2007;73:626–628.
32. Basu S. Metabolism of 8-iso-prostaglandin F2alpha. FEBS Lett. 1998;428:32–36.
33. Violi F, Calvieri C, Ferro D, Pignatelli P. Statins as antithrombotic drugs. Circulation. 2013;127:251–257.
34. Kuhn EW, Liakopoulos OJ, Stange S, Deppe AC, Slottosch I, Choi YH, Wahlers T. Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J Cardiothorac Surg. 2014;45:17–26; discussion 26.
35. Violi F, Pastori D, Pignatelli P, Loffredo L. Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis. Europace. 2014;16:1107–1116.
36. Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: toll-like receptors. Free Radic Biol Med. 2010;48:1121–1132.